Cargando…
Contraception During Perimenopause: Practical Guidance
Climacteric is by no means in itself a contraindication to safe contraception. On the contrary, there are several conditions related to the perimenopause that could benefit from the use of modern contraceptives, mainly hormonal, with the goals of avoiding unintended pregnancies and giving further po...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9296102/ https://www.ncbi.nlm.nih.gov/pubmed/35866143 http://dx.doi.org/10.2147/IJWH.S288070 |
_version_ | 1784750193253548032 |
---|---|
author | Grandi, Giovanni Di Vinci, Pierluigi Sgandurra, Alice Feliciello, Lia Monari, Francesca Facchinetti, Fabio |
author_facet | Grandi, Giovanni Di Vinci, Pierluigi Sgandurra, Alice Feliciello, Lia Monari, Francesca Facchinetti, Fabio |
author_sort | Grandi, Giovanni |
collection | PubMed |
description | Climacteric is by no means in itself a contraindication to safe contraception. On the contrary, there are several conditions related to the perimenopause that could benefit from the use of modern contraceptives, mainly hormonal, with the goals of avoiding unintended pregnancies and giving further possible benefits beyond contraception (menstrual cycle control, a reduction of vasomotor symptoms and menstrual migraines, a protection against bone loss, a positive oncological risk/benefit balance). This narrative review aims to provide practical guidance on their possible use in this particular life stage, both short- and long-acting reversible contraceptives, and to assist clinicians for women transitioning from contraception to their menopausal years, including the possible initiation of postmenopausal hormone therapy. Comprehensive contraceptive counselling is an essential aspect of the overall health and wellbeing of women and should be addressed with each such patient irrespective of age. |
format | Online Article Text |
id | pubmed-9296102 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-92961022022-07-20 Contraception During Perimenopause: Practical Guidance Grandi, Giovanni Di Vinci, Pierluigi Sgandurra, Alice Feliciello, Lia Monari, Francesca Facchinetti, Fabio Int J Womens Health Review Climacteric is by no means in itself a contraindication to safe contraception. On the contrary, there are several conditions related to the perimenopause that could benefit from the use of modern contraceptives, mainly hormonal, with the goals of avoiding unintended pregnancies and giving further possible benefits beyond contraception (menstrual cycle control, a reduction of vasomotor symptoms and menstrual migraines, a protection against bone loss, a positive oncological risk/benefit balance). This narrative review aims to provide practical guidance on their possible use in this particular life stage, both short- and long-acting reversible contraceptives, and to assist clinicians for women transitioning from contraception to their menopausal years, including the possible initiation of postmenopausal hormone therapy. Comprehensive contraceptive counselling is an essential aspect of the overall health and wellbeing of women and should be addressed with each such patient irrespective of age. Dove 2022-07-15 /pmc/articles/PMC9296102/ /pubmed/35866143 http://dx.doi.org/10.2147/IJWH.S288070 Text en © 2022 Grandi et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Review Grandi, Giovanni Di Vinci, Pierluigi Sgandurra, Alice Feliciello, Lia Monari, Francesca Facchinetti, Fabio Contraception During Perimenopause: Practical Guidance |
title | Contraception During Perimenopause: Practical Guidance |
title_full | Contraception During Perimenopause: Practical Guidance |
title_fullStr | Contraception During Perimenopause: Practical Guidance |
title_full_unstemmed | Contraception During Perimenopause: Practical Guidance |
title_short | Contraception During Perimenopause: Practical Guidance |
title_sort | contraception during perimenopause: practical guidance |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9296102/ https://www.ncbi.nlm.nih.gov/pubmed/35866143 http://dx.doi.org/10.2147/IJWH.S288070 |
work_keys_str_mv | AT grandigiovanni contraceptionduringperimenopausepracticalguidance AT divincipierluigi contraceptionduringperimenopausepracticalguidance AT sgandurraalice contraceptionduringperimenopausepracticalguidance AT feliciellolia contraceptionduringperimenopausepracticalguidance AT monarifrancesca contraceptionduringperimenopausepracticalguidance AT facchinettifabio contraceptionduringperimenopausepracticalguidance |